20S proteasome core particle (20S CP)

The 20S proteasome core particle is a barrel-shaped multi-subunit enzyme complex that serves as the catalytic heart of the 26S proteasome, responsible for the degradation of polyubiquitinated proteins within eukaryotic cells (Source: NIH, National Cancer Institute). It consists of four stacked rings: two outer alpha rings that regulate substrate entry and two inner beta rings containing the active proteolytic sites (Source: UniProt, P49721). By degrading regulatory proteins such as cyclins and inhibitors of NF-kappaB, the 20S core particle plays a critical role in controlling the cell cycle, signal transduction, and apoptosis (Source: PubMed, PMID: 21850271). In oncology, the 20S core particle is a validated therapeutic target; drugs like bortezomib and carfilzomib inhibit its activity to induce proteotoxic stress and cell death in cancer cells, particularly in multiple myeloma (Source: StatPearls, Proteasome Inhibitors). Beyond cancer, the 20S proteasome is being investigated for its roles in neurodegeneration and immune-mediated disorders due to its central position in maintaining cellular proteostasis (Source: PubMed, PMID: 30243608).

Other names

20S proteasomeMulticatalytic endopeptidase complex20S core particleProteasome subunit beta type26S proteasome core

Proteasome inhibitors reversibly or irreversibly bind to the N-terminal threonine residues of the catalytic beta subunits (specifically beta-5, beta-2, and beta-1) within the 20S core particle, inhibiting its chymotrypsin-like, trypsin-like, and caspase-like activities. This inhibition leads to the accumulation of misfolded proteins and pro-apoptotic factors, ultimately triggering cell cycle arrest and apoptosis, particularly in malignant cells that are highly dependent on protein turnover.